NIH-funded research U01 cooperative agreement

Platform to Measure How Well Seasonal Flu, COVID-19, and Other Respiratory Vaccines Prevent Illness in Real-Life Settings

Official title: RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings

Funded at Duke University · NIH-11379697 · Data updated 2026-11-12

This grant supports a national effort to track how well respiratory vaccines work in everyday clinics and homes.

More COVID-19 research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2027
Funding year2026
Award (this year)$749,999
NIH project number5U01IP001194-05
Project IDNIH-11379697 on NIH RePORTER

Who could benefit from this research

Could help

Individuals receiving influenza, COVID-19, or other respiratory vaccines, and households participating in vaccine-effectiveness monitoring.

Less likely to help

People not choosing vaccination or not participating in the network may not directly benefit.

What this research studies

This project will coordinate a national network to measure vaccine effectiveness against symptomatic respiratory illness in the community and in households. Duke will manage communications, data handling, and standard procedures so researchers can reliably compare how well influenza, SARS-CoV-2, and other vaccines perform in real-world settings. The work will build on prior experience with clinical studies to collect and analyze data from diverse populations to inform vaccine policy and practice.

Why it matters

Potential benefit: If successful, it could improve vaccine recommendations and public health strategies to prevent respiratory illnesses.

How similar studies have gone: Previous vaccine-effectiveness networks have demonstrated the value of real-world data to guide vaccination programs.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Walter, Emmanuel B — Duke University
  • Study coordinator: Walter, Emmanuel B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.